Cargando…
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics
The Human Viral Challenge (HVC) model has, for many decades, helped in the understanding of respiratory viruses and their role in disease pathogenesis. In a controlled setting using small numbers of volunteers removed from community exposure to other infections, this experimental model enables proof...
Autores principales: | Lambkin-Williams, Rob, Noulin, Nicolas, Mann, Alex, Catchpole, Andrew, Gilbert, Anthony S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013893/ https://www.ncbi.nlm.nih.gov/pubmed/29929556 http://dx.doi.org/10.1186/s12931-018-0784-1 |
Ejemplares similares
-
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process
por: Catchpole, Andrew P., et al.
Publicado: (2018) -
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)